Teleflex Incorporated Common Stock (TFX)

FairStock Score: 16/100 — RISKY

Key Financials

Strengths

• Generates $13 million in annual free cash flow (0.2% yield on market cap)
• Established organization with 15,500 employees providing operational scale

Concerns

• Trades significantly above Graham Number ($46) with negative 196% margin of safety—limited downside protection
• Currently unprofitable—sustained losses could lead to dilutive capital raises or balance sheet deterioration
• Revenue declining at 150.5% year-over-year signals potential demand weakness or market share loss
• Weak Piotroski F-Score of 2/9 suggests deteriorating financial quality across multiple dimensions

AI Analysis

Teleflex Incorporated Common Stock is a small-cap healthcare company valued at $6.0 billion. Revenue stands at $2.0 billion, though the company is currently unprofitable. From a quality standpoint, Teleflex shows weak Piotroski F-Score of 2/9 signaling deteriorating fundamentals and distressed Altman Z-Score of 1.6 warrants caution. On valuation, the stock is commanding a steep 104.3x multiple, with trades far above its Graham Number ($46) with no margin of safety. Growth dynamics show revenue growing at -150.5% and profit growth of -422.7%. Our composite FairStock Score of 16/100 reflects below-average fundamentals overall. Without profitability, this remains speculative—suitable only for those with high risk tolerance and a long time horizon.

Bull Case

Improving fundamentals and sector tailwinds could drive meaningful earnings growth, compressing the effective multiple for patient investors. With $13 million in annual free cash flow (0.2% yield), management has ample capital for buybacks, dividends, or accretive acquisitions.

Bear Case

At 104x earnings, any growth disappointment triggers rapid multiple compression—a 20% earnings miss plus multiple contraction to 20x implies 40%+ downside. Regulatory changes, input cost inflation, or demand normalization represent underappreciated risks that could materially impact forward estimates.

Data from SEC filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer